BBWI
Bath & Body Works Inc
$
22.190
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
22.6647
Open
22.290
VWAP
22.28
Vol
1.57M
Mkt Cap
4.62B
Low
22.065
Amount
34.91M
EV/EBITDA(TTM)
5.32
Total Shares
223.23M
EV
8.14B
EV/OCF(TTM)
8.14
P/S(TTM)
0.65
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
1.65B
+2.18%
0.404
-17.52%
2.86B
+2.53%
2.198
+5.17%
1.47B
+2.97%
0.509
+3.81%
Estimates Revision
The market is revising Downward the revenue expectations for Bath & Body Works, Inc. (BBWI) for FY2026, with the revenue forecasts being adjusted by -0.27% over the past three months. During the same period, the stock price has changed by -25.03%.
Revenue Estimates for FY2026
Revise Downward
-0.27%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
-0.84%
In Past 3 Month
Stock Price
Go Down
-25.03%
In Past 3 Month
12 Analyst Rating
Wall Street analysts forecast BBWI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBWI is 34.96 USD with a low forecast of 26.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
0 Sell
Moderate Buy
Current: 22.190
Low
26.00
Averages
34.96
High
40.00
Current: 22.190
Low
26.00
Averages
34.96
High
40.00
Raymond James
Olivia Tong
Outperform -> Market Perform
downgrade
2025-11-12
New
Reason
Raymond James
Olivia Tong
Price Target
2025-11-12
New
downgrade
Outperform -> Market Perform
Reason
Raymond James analyst Olivia Tong downgraded Bath & Body Works to Market Perform from Outperform without a price target. The company's growth will be below its long-term potential as improvements from better digital capabilities, product, and distribution will take time, the analyst tells investors in a research note. The firm's channel checks in the last two months suggest Bath & Body's recent innovations "have fallen short" while discounting in stores and online has increased. Raymond James cut estimates and downgraded the shares on the company's near-term challenges.
Wells Fargo
Overweight
to
NULL
downgrade
$44 -> $33
2025-10-27
Reason
Wells Fargo
Price Target
$44 -> $33
2025-10-27
downgrade
Overweight
to
NULL
Reason
Wells Fargo lowered the firm's price target on Bath & Body Works to $33 from $44 and keeps an Overweight rating on the shares. The firm is also cutting Q3 estimates, and more notably pruning 2026 EPS well below Street. Wells believes turnaround efforts are likely to be pushed out to 2026 as new CEO Heaf takes more time to reinvest in the current model.
Barclays
Equal Weight
downgrade
$32 -> $28
2025-10-20
Reason
Barclays
Price Target
$32 -> $28
2025-10-20
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Bath & Body Works to $28 from $32 and keeps an Equal Weight rating on the shares after meeting with management. The firm believes Bath & Body's "focus on fewer" strategy and brand strength will drive a business inflection in the second half of 2026.
Morgan Stanley
Alex Straton
Overweight
downgrade
$41 -> $40
2025-09-12
Reason
Morgan Stanley
Alex Straton
Price Target
$41 -> $40
2025-09-12
downgrade
Overweight
Reason
Morgan Stanley analyst Alex Straton lowered the firm's price target on Bath & Body Works to $40 from $41 and keeps an Overweight rating on the shares after updating the firm's estimates post-Q2 results.
Barclays
Adrienne Yih
Equal Weight
maintain
$30 -> $32
2025-08-29
Reason
Barclays
Adrienne Yih
Price Target
$30 -> $32
2025-08-29
maintain
Equal Weight
Reason
Barclays analyst Adrienne Yih raised the firm's price target on Bath & Body Works to $32 from $30 and keeps an Equal Weight rating on the shares following the fiscal Q2 report. The firm says Bath & Body's tariff impacts will be largest in Q3, as inventory flows-through.
UBS
Neutral
downgrade
$36 -> $32
2025-08-29
Reason
UBS
Price Target
$36 -> $32
2025-08-29
downgrade
Neutral
Reason
UBS lowered the firm's price target on Bath & Body Works to $32 from $36 and keeps a Neutral rating on the shares following the Q2 report. The firm sees limited upside to the Street's fiscal 2025 earnings estimates. Bath & Body has few levers to drive margin upside and new CEO Daniel Heaf's wholesale channel expansion strategy could further pressure its EBIT margin expansion, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Bath & Body Works Inc (BBWI.N) is 6.44, compared to its 5-year average forward P/E of 12.32. For a more detailed relative valuation and DCF analysis to assess Bath & Body Works Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
12.32
Current PE
6.44
Overvalued PE
15.25
Undervalued PE
9.39
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
9.24
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.81
Undervalued EV/EBITDA
7.67
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.60
Current PS
22.40
Overvalued PS
3.95
Undervalued PS
-0.75
Financials
Annual
Quarterly
FY2026Q2
YoY :
+1.51%
1.55B
Total Revenue
FY2026Q2
YoY :
-14.21%
157.00M
Operating Profit
FY2026Q2
YoY :
-57.89%
64.00M
Net Income after Tax
FY2026Q2
YoY :
-55.88%
0.30
EPS - Diluted
FY2026Q2
YoY :
-1.98%
-99.00M
Free Cash Flow
FY2026Q2
YoY :
+0.73%
41.32
Gross Profit Margin - %
FY2026Q2
YoY :
+14.32%
10.62
FCF Margin - %
FY2026Q2
YoY :
-58.53%
4.13
Net Margin - %
FY2026Q2
YoY :
-22.57%
38.53
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
3.0M
Volume
6
0-12
Months
3.7M
Volume
8
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
3
2.9M
Volume
Months
0-12
7
5.5M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
BBWI News & Events
Events Timeline
2025-11-04 (ET)
2025-11-04
09:03:41
Bath & Body Works Appoints Maly Bernstein as Chief Commercial Officer and Samantha Charleston as Chief Human Resources Officer
2025-09-25 (ET)
2025-09-25
19:13:37
Trump intends to implement a 50% tariff on kitchen cabinets and bathroom vanities.
2025-09-08 (ET)
2025-09-08
09:06:32
Bath & Body Works Plans to Recruit More Than 30,000 Seasonal Workers for the Holiday Season
Sign Up For More Events
Sign Up For More Events
News
4.0
11-12BenzingaBath & Body Works Analyst Changes Stance; Check Out Wednesday's Top 4 Downgrades
8.0
11-10NASDAQ.COMSignificant Options Trading on Monday: LXU, BBWI, CXW
8.0
11-07NewsfilterBath & Body Works Announces Cash Dividend Payment
Sign Up For More News
People Also Watch
AM
Antero Midstream Corp
17.635
USD
-1.54%
G
Genpact Ltd
45.415
USD
-0.27%
BRX
Brixmor Property Group Inc
26.530
USD
-0.23%
MTDR
Matador Resources Co
41.160
USD
+3.21%
LNW
Light & Wonder Inc
88.840
USD
-3.86%
HII
Huntington Ingalls Industries Inc
315.530
USD
-0.74%
KBR
KBR Inc
42.560
USD
+0.07%
CE
Celanese Corp
39.900
USD
+1.99%
WF
Woori Financial Group Inc
55.480
USD
-0.91%
AXTA
Axalta Coating Systems Ltd
29.590
USD
+0.92%
FAQ
What is Bath & Body Works Inc (BBWI) stock price today?
The current price of BBWI is 22.19 USD — it has decreased -0.94 % in the last trading day.
What is Bath & Body Works Inc (BBWI)'s business?
What is the price predicton of BBWI Stock?
What is Bath & Body Works Inc (BBWI)'s revenue for the last quarter?
What is Bath & Body Works Inc (BBWI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Bath & Body Works Inc (BBWI)'s fundamentals?
How many employees does Bath & Body Works Inc (BBWI). have?